Strongyloides stercoralis Hyperinfection in Pemphigus Vulgaris: A Neglected Preventable Fatality

Nathkapach Kaewpitoon Rattanapitoon; Natthawut Charoenphon; Khristine Laguador Sandoval; Schawanya Kaewpitoon Rattanapitoon

doi:10.20344/amp.23728

Strongyloides stercoralis Hyperinfection in Pemphigus Vulgaris: A Neglected Preventable Fatality

Authors

Nathkapach Kaewpitoon Rattanapitoon Parasitic Disease Research. FMC Medical Center. Nakhon Ratchasima. https://orcid.org/0000-0002-2806-2129
Natthawut Charoenphon Faculty of Medical Science. Naresuan University. Pitsanulok. https://orcid.org/0000-0002-4260-5038
Khristine Laguador Sandoval School of Arts and Sciences. National University. Philippines. Pasay City. https://orcid.org/0000-0001-8273-7265
Schawanya Kaewpitoon Rattanapitoon Parasitic Disease Research. FMC Medical Center. Nakhon Ratchasima. https://orcid.org/0000-0002-9391-5642

DOI:

https://doi.org/10.20344/amp.23728

Keywords:

Immunosuppressive Agents/adverse effects, Pemphigus/drug therapy, Strongyloides stercoralis, Strongyloidiasis/chemically induced, Strongyloidiasis/diagnosis, Strongyloidiasis/drug therapy, Superinfection

Abstract

n/a.

Downloads

Download data is not yet available.

References

Tribolet de Abreu I, de Vasconcelos P, Moiteiro da Cruz R, Soares-Almeida L, Filipe P. Nonfatal strongyloides stercoralis hyperinfection secondary to pemphigus vulgaris immunosuppressant treatment: case report and brief literature review. Acta Med Port. 2025;38:427-32. DOI: https://doi.org/10.20344/amp.22948

Mejia R, Nutman TB. Screening, prevention, and treatment for hyperinfection syndrome and disseminated infections caused by strongyloides stercoralis. Curr Opin Infect Dis. 2012;25:458-63. DOI: https://doi.org/10.1097/QCO.0b013e3283551dbd

Requena-Méndez A, Buonfrate D, Gomez-Junyent J, Zammarchi L, Bisoffi Z, Muñoz J. Evidence-based guidelines for screening and management of strongyloidiasis in non-endemic countries. Am J Trop Med Hyg. 2017;97:645-52. DOI: https://doi.org/10.4269/ajtmh.16-0923

Keiser PB, Nutman TB. Strongyloides stercoralis in the immunocompromised population. Clin Microbiol Rev. 2004;17:208-17. DOI: https://doi.org/10.1128/CMR.17.1.208-217.2004

Buonfrate D, Requena-Mendez A, Angheben A, Muñoz J, Gobbi F, Van Den Ende J, et al. Severe strongyloidiasis: a systematic review of case reports. BMC Infect Dis. 2013;13:78. DOI: https://doi.org/10.1186/1471-2334-13-78

Schär F, Trostdorf U, Giardina F, Khieu V, Muth S, Marti H, et al. Strongyloides stercoralis: global distribution and risk factors. PLoS Negl Trop Dis. 2013;7:e2288. DOI: https://doi.org/10.1371/journal.pntd.0002288

Román-Sánchez P, Pastor-Guzmán A, Moreno-Guillén S, Igual-Adell R, Suñer-Generoso S, Tornero-Estébanez C. High prevalence of Strongyloides stercoralis among farm workers on the Mediterranean coast of Spain: analysis of the predictive factors of infection in developed countries. Am J Trop Med Hyg. 2003;69:336-40. DOI: https://doi.org/10.4269/ajtmh.2003.69.336

Downloads

Published

2025-12-02

How to Cite

Kaewpitoon Rattanapitoon N, Charoenphon N, Laguador Sandoval K, Kaewpitoon Rattanapitoon S. Strongyloides stercoralis Hyperinfection in Pemphigus Vulgaris: A Neglected Preventable Fatality. Acta Med Port [Internet]. 2025 Dec. 2 [cited 2025 Dec. 5];38(12):838-9. Available from: https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/23728

Download Citation

Issue

Vol. 38 No. 12 (2025): December

Section

Letters to the Editor

License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

All the articles published in the AMP are open access and comply with the requirements of funding agencies or academic institutions. The AMP is governed by the terms of the Creative Commons ‘Attribution – Non-Commercial Use - (CC-BY-NC)’ license, regarding the use by third parties.

It is the author’s responsibility to obtain approval for the reproduction of figures, tables, etc. from other publications.

Upon acceptance of an article for publication, the authors will be asked to complete the ICMJE “Copyright Liability and Copyright Sharing Statement “(http://www.actamedicaportuguesa.com/info/AMP-NormasPublicacao.pdf) and the “Declaration of Potential Conflicts of Interest” (http:// www.icmje.org/conflicts-of-interest). An e-mail will be sent to the corresponding author to acknowledge receipt of the manuscript.

After publication, the authors are authorised to make their articles available in repositories of their institutions of origin, as long as they always mention where they were published and according to the Creative Commons license.